Life science software for clinical research, medical affairs, and regulatory data
Anju builds software for pharmaceutical, CRO, and medical device companies managing clinical research workflows and regulatory data. The tech stack reveals an AI-forward engineering org: Python + Node.js backbone, Claude + Codex + LangChain actively adopted, and a RAG pipeline in flight for life sciences data. Active projects span workflow automation, regulatory compliance AI, and a new AI product from scratch — while pain points flag legacy AI architecture and roadmap constraints, suggesting a rapid pivot toward modern generative AI capabilities.
Anju Software provides software solutions for clinical research, medical affairs, and data science across pharmaceutical companies, CROs, and medical device manufacturers. The company operates three core products: TrialMaster, IRMS MAX, and TA Scan, designed to streamline drug and device discovery and commercialization workflows. Anju is a portfolio company of Valsoft Corporation, a Canadian-based operator of vertical market software businesses. The organization spans 201–500 employees, headquartered in Tempe, Arizona, with current hiring activity in the United States, South Africa, and Canada.
Core: Python, Node.js. AI/ML: Claude, Codex, LangChain, GPT-4, RAG. Operations: Jira, NetSuite, Teams. Creative/marketing: Figma, Adobe Creative Cloud, Canva. Actively adopting Claude, Codex, LangChain, and RAG pipelines.
Workflow discovery automation, regulatory compliance AI features, a RAG pipeline for life sciences data, rapid automation tooling, and an AI product built from scratch. Beta programs and customer pilots are underway.
Other companies in the same industry, closest in size